The question
Chronic low-dose BMAA in flies expressing human TDP-43 (wild-type and the M337V mutation), with L-serine as a possible block. The prediction is that neither hit is enough alone, and only flies with both the mutation and the toxin cross the failure threshold. There's no data yet: this is the plan.



